Alcohol Consumption Emerges as a Key Risk Factor for Buccal Cancer in India
December 24, 2025
Brand Name :
N/A
Synonyms :
rimiterol
Class :
Bronchodilator
Dosage Forms & Strengths
Dry powder (inhaler)
250 mcg/dose
Chronic Obstructive Pulmonary Disease (COPD)
As metered-dose aerosol:
Inhaled dose of 250 to 500 mcg when required
Dose should not be more than 8 times in a day
Do not repeat dose in less than 1 hour
Not determined
Refer to adult dosing
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
Actions and Spectrum
rimiterol is a direct-acting sympathomimetic having selective action on 2-receptors and adrenergic activity.
Frequency not defined
Palpitations
Muscle cramps
Tachycardia
Nervous tension
headache
Peripheral vasodilatation
Hypersensitivity reactions
Black Box Warning
None
Contraindication/Caution:
None
Pregnancy consideration:
Pregnancy category: N/A
Lactation: Excretion into human milk is unknown
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
rimiterol is a direct-acting sympathomimetic that primarily inhibits adrenergic activity while selectively acting on 2-receptors.
Pharmacodynamics
None
Pharmacokinetics
Limited information available on ADME
Administration
rimiterol is administered via inhalation using a metered-dose inhaler (MDI).
Patient information leaflet
Generic Name: rimiterol
Why do we use rimiterol?
rimiterol is used for the treatment of respiratory conditions characterized by bronchodilation.
rimiterol is also used in the management of COPD, which includes conditions like asthma.